DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

Phase 1

Completed

Conditions: Locally Advanced Non-Small Cell Lung Cancer

Interventions: Drug: Atovaquone Oral Suspension
Drug: Standard of care chemotherapy
Radiation: Standard of care radiotherapy

First Posted Date: 2020-12-01

Last Posted Date: 2025-02-27

Lead Sponsor: University of Oxford

Target Recruit Count: 21

Registration Number: NCT04648033

Locations: 🇬🇧
Western General Hospital, NHS Lothian, Edinburgh, United Kingdom
🇬🇧
Guy's and St Thomas', London, United Kingdom
🇬🇧
Churchill Hospital, Oxford University Hospitals, Oxford, United Kingdom

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia

Recruiting

Conditions: Acute Febrile Illness

First Posted Date: 2020-11-16

Last Posted Date: 2024-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 7200

Registration Number: NCT04629053

Locations: 🇧🇩
Building Resources Across Communities (BRAC), Dhaka, Bangladesh
🇱🇦
Laos-Oxford-Mahosot Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic
🇹🇭
Chiangrai Clinical Research Unit (CCRU), Chiang Rai, Thailand

and more 1 locations

Defining Causes of Deaths in South and Southeast Asia

Recruiting

Conditions: Cause of Neonatal Death
Cause of Mortality
Cause of Maternal Death
Cause of Child Death
Cause of Adult Death

First Posted Date: 2020-10-20

Last Posted Date: 2023-01-20

Lead Sponsor: University of Oxford

Target Recruit Count: 2000

Registration Number: NCT04595656

Locations: 🇧🇩
Building Resources Across Communities (BRAC), Dhaka, Bangladesh
🇰🇭
Action for Health Development (AHEAD), Battambang, Cambodia
🇱🇦
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Vientiane, Lao People's Democratic Republic

and more 2 locations

A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

Phase 1

Completed

Conditions: HIV

Interventions: Biological: ChAdOx1.tHIVconsv1 (C1)
Biological: MVA.tHIVconsv3 (M3)
Biological: MVA.tHIVconsv4 (M4)

First Posted Date: 2020-10-14

Last Posted Date: 2025-04-29

Lead Sponsor: University of Oxford

Target Recruit Count: 13

Registration Number: NCT04586673

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

The Microbiology of Pleural Infection

Completed

Conditions: Pleural Infection
Pleural Infection Bacterial

Interventions: Other: Not applicable. Observational study. Retrospective analysis of samples.

First Posted Date: 2020-09-29

Last Posted Date: 2020-10-01

Lead Sponsor: University of Oxford

Target Recruit Count: 251

Registration Number: NCT04569110

Locations: 🇬🇧
Laboratory of Pleural Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: ChAdOx1.HTI and MVA.HTI

First Posted Date: 2020-09-24

Last Posted Date: 2022-09-01

Lead Sponsor: University of Oxford

Target Recruit Count: 10

Registration Number: NCT04563377

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom

Enhanced Detection in Glioma Excision

Not Applicable

Terminated

Conditions: Glioma

Interventions: Diagnostic Test: Intra-operative imaging of 5-ALA fluorescence using ultra-high sensitivity camera
Diagnostic Test: Intra-operative imaging of 5-ALA fluorescence using in-built operative microscope camera
Diagnostic Test: Biopsies

First Posted Date: 2020-09-21

Last Posted Date: 2024-03-22

Lead Sponsor: University of Oxford

Target Recruit Count: 4

Registration Number: NCT04556929

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

A Study to Test Three Experimental HIV Vaccines in Healthy Adults.

Phase 1

Conditions: HIV-1-infection

Interventions: Biological: Vaccine
Biological: Placebo

First Posted Date: 2020-09-17

Last Posted Date: 2022-06-22

Lead Sponsor: University of Oxford

Target Recruit Count: 88

Registration Number: NCT04553016

Locations: 🇺🇬
Medical Research and Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Masaka, Uganda
🇿🇲
Center for Family Health Research in Zambia, Lusaka, Zambia
🇰🇪
Kenya Medical Research Institute Wellcome Trust Programme, Kilifi, Kenya

and more 1 locations

The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study

Recruiting

Conditions: Critical Illness
Stroke
Atrium; Fibrillation
Atrial Flutter
Myocardial Infarction

Interventions: Other: Admission to ICU

First Posted Date: 2020-09-11

Last Posted Date: 2023-04-20

Lead Sponsor: University of Oxford

Target Recruit Count: 80000

Registration Number: NCT04545437

Locations: 🇬🇧
Oxford University Hospitals, Oxford, Oxfordshire, United Kingdom
🇬🇧
Royal Berkshire NHS Foundation Trust, Reading, Berkshire, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

Phase 2

Active, not recruiting

Conditions: MALNUTRITION, CHILD
SEPSIS

Interventions: Other: Pancreatic Enzyme placebo
Other: Ursodeoxycholic acid placebo
Drug: Pancreatic Enzyme
Drug: Ursodeoxycholic acid

First Posted Date: 2020-09-09

Last Posted Date: 2023-02-24

Lead Sponsor: University of Oxford

Target Recruit Count: 400

Registration Number: NCT04542473

Locations: 🇺🇬
Mulago Hospital, Kampala, Uganda
🇲🇼
Queen Elizabeth Central Hospital, Blantyre, Malawi
🇰🇪
KEMRI WT Clinical Trials Facility, Kilifi, Kenya

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy